Heer Lab

Professor of Urology. Investigating stem cell biology and cancer.

[Heer Lab @Heer_Lab]

A Tweetorial – Does PHOTOdynamic Surgery in Non–Muscle-Invasive Bladder Cancer reduce recurrence?

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

Proud to chair the 5th annual IBCG Bladder Cancer Forum at #AUA26 alongside an extraordinary group of global colleagues, thought leaders, and patient advocates committed to advancing care for patients with bladder cancer.

What began five years ago as a vision for open, high-level, multidisciplinary dialogue has grown into one of the most engaging and collegial forums at the meeting. This year’s debates and discussions once again reflected the passion, expertise, and shared purpose of this community.

My sincere thanks to all of the speakers, moderators, panelists, advocates, and attendees who made the session such a success.

#AUA2026 @IBCG_BladderCA #BladderCancer @BladderCancerUS @WorldBladderCan

[UroToday.com @urotoday]

Tracking circulating tumor DNA in patients undergoing chemoradiation for #BladderCancer. @mouwlab @DanaFarber joins @l_ballas @CedarsSinai to discuss ctDNA dynamics using the Signatera assay in 84 muscle-invasive bladder cancer patients receiving trimodal therapy across Boston institutions. #WatchNow > https://t.co/rsUompL2Yi

[Prof Veeru Kasi @veerukasi]

For UK healthcare professionals (HCPs) only 

If you’re not an HCP, information for the public is available at: https://t.co/tdwHYFZRKq

UK HCPs can access my video on the topic below using this link: https://t.co/A1x1tAYlQq

Organised and funded by Astellas Pharma Ltd.

[ProstateCancerResearch @PCR_News]

"Taking part in research like clinical trials is important for Black men" - Alfred, Advanced Prostate Cancer survivor.

To learn more about Ethnicity and clinical trials visit the infopool: https://t.co/Zh3XTO8XfR

[Nature Reviews Cancer @NatureRevCancer]

NEW content online! Mesenchymal stromal/stem cells in tumour initiation, progression and therapy https://t.co/ahVSqCbBzg

[💙alison birtle @AlisonBirtle]

Here is a Treatment algorithm for Bone health management in patients with prostate cancer on @OpenMedicineHQ. Interactive, evidence-linked, open for discussion. Feedback welcome. #LivingAlgorithms
https://t.co/J7fMUb5ahP

[Heer Lab @Heer_Lab]

@TUF_tweets Outstanding appointment of an outstanding surgeon scientist 👏🏽

[TheUrologyFoundation @TUF_tweets]

Introducing Professor Imran Ahmad, our new SEC Chair. Learn more about his remarkable work: https://t.co/trc3YDlxyv

Drawn to TUF for our “unique ability to support early‑stage, clinically relevant research.”

We’re proud to have him shaping TUF’s research future.

[TheUrologyFoundation @TUF_tweets]

Next week, our Bike4TUF cyclists begin their ride from Newcastle to Glasgow in aid of The Urology Foundation.

We extend our sincere thanks to Rigicon for their generous sponsorship of the team’s cycling jerseys for the Bike4TUF fundraising event.

#Bike4TUF #ThankYou

[Enrique Grande @drenriquegrande]

⚡️ KEYNOTE-905 published in @NEJM: perioperative enfortumab vedotin + pembrolizumab vs surgery alone in cisplatin-ineligible MIBC (n=344).

2-year EFS: 74.7% vs 39.4% (HR 0.40)
2-year OS: 79.7% vs 63.1% (HR 0.50)
pCR: 57.1% vs 8.6%

The trial that supported FDA approval in November 2025 — now with full data.

https://t.co/3FsYt3ZuEJ

#BladderCancer

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

ASCO Abstract 4624 - POTOMAC OS data at #ASCO26 in 8 days.

Worth noting that POTOMAC included TaHG tumors as high risk, mirroring what clinicians taking care of bladder cancer patients do, in real life.

The expanded papillary subgroup analysis at #AUA26 last week showed why that matters: in papillary-only disease (including TaHG tumors) -- 64% of the trial -- HR for DFS events was 0.56 (p=0.0046). Even stronger than the ITT effect.

More to come ��

[Dr Heminder Kaur Sokhi @HemmySokhi]

Recruitment for the very exciting IP7-PACIFIC RCT [(1) bpMRI vs mpMRI (2) image-fusion vs visual registration targeted biopsies] is still ongoing! ~ 1900 of ~ 2700 target recruited; UK based centres welcome to join!

https://t.co/CECRYg0go9

@IP_London @LondonProstate1

[ProstateUK Profs @ProstateUKProfs]

The April edition of Research News is here! Read about:

💙 The TRANFORM screening trial.
📢 Our new LinkedIn channel for prostate cancer researchers.
🔬 Research stories with impact.
🏆 Researcher achievements.
💰 Funding opportunities.

Read it here 📰 : https://t.co/4gqMGqF7og

[ProstateCancerResearch @PCR_News]

WE WON! 🏆

Our Supporter Insight and Experience Project has won Most Powerful Use of Insight to Improve Supporter Experience at the CIOF Insight in Fundraising Awards!

[ACE (formerly HSRU) @ace_aberdeen]

ELIPSE had another successful PMG!

[ProstateCancerResearch @PCR_News]

The grade of your cancer tells your doctor how abnormal the cancer cells look under a microscope.
To learn more, visit the infopool: https://t.co/UWf0s3ahLr

[TheUrologyFoundation @TUF_tweets]

May is #BladderCancerAwarenessMonth

For more information on the signs and symptoms of bladder cancer, visit our website: https://t.co/cAPGRgrzh1

#urology #bladder #bladderhealth #BladderCancer #BladderCancerMonth26

[Cell @CellCellPress]

In the latest issue! Microbiome-produced nicotinic acid controls colon regional identity and injury susceptibility https://t.co/Xfi2ot34tu

[ACE (formerly HSRU) @ace_aberdeen]

Delighted to share that our @GilliesKatie has been elected as a Board member for @SCTorg

SCT is a scientific, educational, & charitable organization whose international purpose advances human health through advocating for use of, dissemination, & training in clinical trials

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

Excited to be part of this important event the day before #AUA2026 kicks off.

When Treatment Shapes Life - a session featuring new data from a global survey on the lived experience of bladder cancer patients and urologists.

May 14 | National Press Club, Washington D.C.
Hosted with @WorldBladderCan @BladderCancerUS @IBCG_BladderCA moderated by Gina Carithers @UroToday and featuring: @filicevas @MargoWickersham Meri-Margaret Deoudes

#BladderCancer #BladderCancerAwarenessMonth #AUA26

Register here: https://t.co/OVzKexrIYK